Divi's Laboratories inks pact with global pharma company

26 May 2025 Evaluate

Divi's Laboratories has signed long term manufacturing and supply agreement with a global pharma company. Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties. The cost of capacity addition for manufacturing under this agreement is estimated to be Rs 650 to Rs 750 crore, which will be funded from the capacity reservation advance proposed to be paid by the customer phase wise under this Agreement.

Divi's Laboratories is one of the leading pharmaceutical companies in the world.

Divis Lab Share Price

6342.60 -52.05 (-0.81%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×